Pomegranate extract modulates processing of amyloid-β precursor protein in an aged Alzheimer’s disease animal model

Current Alzheimer Research

Volumn 11, Issue 9, 2014, Pages 834-843

  Ahmed, Aseef H ^a   Subaiea, Gehad M ^a   Eid, Aseel ^a   Li, Liya ^a   Seeram, Navindra P ^a   Zawia, Nasser H ^a  

^a UNIVERSITY OF RHODE ISLAND   (United States)

Author keywords

Alzheimer s disease; Amyloid protein; Gamma secretase; Polyphenols; Pomegranate

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN[1-40]; AMYLOID BETA PROTEIN[1-42]; AMYLOID PRECURSOR PROTEIN; GAMMA SECRETASE; POMEGRANATE EXTRACT; AMYLOID BETA-PROTEIN (1-42); BIOLOGICAL MARKER; NEUROPROTECTIVE AGENT; PEPTIDE FRAGMENT; PLANT EXTRACT; SECRETASE;

AGED; ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; BRAIN TISSUE; COGNITION; CONTROLLED STUDY; DRUG MECHANISM; ENZYME ACTIVITY; HIPPOCAMPUS; LONG TERM MEMORY; MEMORY; MORRIS WATER MAZE TEST; NONHUMAN; PATHOGENESIS; WORKING MEMORY; Y-MAZE TEST; AGING; ANIMAL; BRAIN; DISEASE MODEL; DRUG EFFECTS; FEMALE; GENETICS; LYTHRACEAE; MAZE TEST; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; PHYTOTHERAPY; SHORT TERM MEMORY; SPATIAL MEMORY; TRANSGENIC MOUSE;

AGING; ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; AMYLOID BETA-PROTEIN PRECURSOR; AMYLOID PRECURSOR PROTEIN SECRETASES; ANIMALS; BIOMARKERS; BRAIN; DISEASE MODELS, ANIMAL; FEMALE; MAZE LEARNING; MEMORY, LONG-TERM; MEMORY, SHORT-TERM; MICE, TRANSGENIC; NEUROPROTECTIVE AGENTS; PEPTIDE FRAGMENTS; PHYTOTHERAPY; PLANT EXTRACTS; PUNICACEAE; SPATIAL MEMORY;

EID: 84911364640     PISSN: 15672050     EISSN: 18755828     Source Type: Journal    
DOI: 10.2174/1567205011666141001115348     Document Type: Article

References (69)

1. Hebert LE, Scherr PA, Bienias JL, Bennett DA, Evans DA. Alzheimer disease in the US population: prevalence estimates using the 2000 census. Archf Neurol 60: 1119-1122 (2003).
2. Alzheimer's Association (2014) 2014 Alzheimer's disease facts and figures. Alzheimers Dement 10: e47-e92 (2014).
3. Alonso A, Zaidi T, Novak M, Grundke-Iqbal I, Iqbal K. Hyperphosphorylation induces self-assembly of tau into tangles of paired helical filaments/straight filaments. Proc Natl Acad Sci 98: 6923-6928 (2001).
4. Haass C, Selkoe DJ. Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid beta-peptide. Nat Rev Mol Cell Biol 8: 101-112 (2007).
5. Hardy J, Higgins GA. Alzheimer's disease: the amyloid cascade hypothesis. Science 256: 184-185 (1992).
6. Selkoe DJ. Physiological production of the beta-amyloid protein and the mechanism of Alzheimer's disease. Trends Neurosci 16: 403-409 (1993).
7. Solfrizzi V, Panza F, Frisardi V, Seripa D, Logroscino G, Imbimbo BP, et al. Diet and Alzheimer's disease risk factors or prevention: the current evidence. Expert Rev Neurother 11: 677-708 (2011).
8. Lim GP, Chu T, Yang F, Beech W, Frautschy SA, Cole GM. The curry spice curcumin reduces oxidative damage and amyloid pathology in an Alzheimer transgenic mouse. J Neurosci 21: 8370-8377 (2001).
9. Cole GM, Teter B, Frautschy SA. Neuroprotective effects of curcumin. Adv Exp Med Biol 595: 197-212 (2007).
10. Chonpathompikunlert P, Wattanathorn J, Muchimapura S. Piperine, the main alkaloid of Thai black pepper, protects against neurodegeneration and cognitive impairment in animal model of cognitive deficit like condition of Alzheimer's disease. Food Chem Toxicol 48: 798-802 (2010).
11. Frydman-Marom A, Levin A, Farfara D, Benromano T, Scherzer-Attali R, Peled S, et al. Orally administrated cinnamon extract reduces beta-amyloid oligomerization and corrects cognitive impairment in Alzheimer's disease animal models. PLoS One 6: e16564 (2011).
12. Willis LM, Shukitt-Hale B, Cheng V, Joseph JA. Dose-dependent effects of walnuts on motor and cognitive function in aged rats. Br J Nutr 101: 1140-1144 (2009).
13. Muthaiyah B, Essa MM, Chauhan V, Chauhan A. Protective effects of walnut extract against amyloid beta peptide-induced cell death and oxidative stress in PC12 cells. Neurochem Res 36: 2096-2103 (2011).
14. Essa MM, Vijayan RK, Castellano-Gonzalez G, Memon MA, Braidy N, Guillemin GJ. Neuroprotective effect of natural products against Alzheimer's disease. Neurochem Res 37: 1829-1842 (2012).
15. Choi DY, Lee YJ, Hong JT, Lee HJ. Antioxidant properties of polyphenols and their therapeutic potentials for Alzheimer's disease. Brain Research Bulletin 144-153 (2012).
16. Vepsalainen S, Koivisto H, Pekkarinen E, Makinen P, Dobson G, McDougall GJ, et al. Anthocyanin-enriched bilberry and blackcurrant extracts modulate amyloid precursor protein processing and alleviate behavioral abnormalities in the APP/PS1 mouse model of Alzheimer's disease. J Nutr Biochem 24: 360-370 (2013).
17. Siahmard Z, Alaei H, Reisi P, Pilehvarian AA. The effect of red grape juice on Alzheimer's disease in rats. Adv Biomed Res 1: 63 (2012).
18. Shukitt-Hale B, Cheng V, Joseph JA. Effects of blackberries on motor and cognitive function in aged rats. Nutr Neurosci 12: 135-140 (2009).
19. Andres-Lacueva C, Shukitt-Hale B, Galli RL, Jauregui O, Lamuela-Raventos RM, Joseph JA. Anthocyanins in aged blueberry-fed rats are found centrally and may enhance memory. Nutr Neurosci 8: 111-120 (2005).
20. Kelawala NS, Ananthanarayan L. Antioxidant activity of selected foodstuffs. Int J Food Sci Nutr 55: 511-516 (2004).
21. Loren DJ, Seeram NP, Schulman RN, Holtzman DM. Maternal dietary supplementation with pomegranate juice is neuroprotective in an animal model of neonatal hypoxic-ischemic brain injury. Pediatr Res 57: 858-864 (2005).
22. Seeram NP, Aviram M, Zhang Y, Henning SM, Feng L, Dreher M, et al. Comparison of antioxidant potency of commonly consumed polyphenol-rich beverages in the United States. J Agric Food Chem 56: 1415-1422 (2008).
23. Cerda B, Llorach R, Ceron JJ, Espin JC, Tomas-Barberan FA. Evaluation of the bioavailability and metabolism in the rat of punicalagin, an antioxidant polyphenol from pomegranate juice. Eur J Nutr 42: 18-28 (2003).
24. Cerda B, Espin JC, Parra S, Martinez P, Tomas-Barberan FA. The potent in vitro antioxidant ellagitannins from pomegranate juice are metabolised into bioavailable but poor antioxidant hydroxy-6Hdibenzopyran-6-one derivatives by the colonic microflora of healthy humans. Eur J Nutr 43: 205-220 (2004).
25. Seeram NP, Henning SM, Zhang Y, Suchard M, Li Z, Heber D. Pomegranate juice ellagitannin metabolites are present in human plasma and some persist in urine for up to 48 hours. J Nutr 136: 2481-2485 (2006).
26. Choi SJ, Lee JH, Heo HJ, Cho HY, Kim HK, Kim CJ, et al. Punica granatum protects against oxidative stress in PC12 cells and oxidative stress-induced Alzheimer's symptoms in mice. J Med Food 14: 695-701 (2011).
27. Kwak HM, Jeon SY, Sohng BH, Kim JG, Lee JM, Lee KB, et al. Beta-Secretase (BACE1) inhibitors from pomegranate (Punica granatum) husk. Arch Pharm Res 28: 1328-1332 (2005).
28. Feng Y, Yang SG, Du XT, Zhang X, Sun XX, Zhao M, et al. Ellagic acid promotes Abeta42 fibrillization and inhibits Abeta42-induced neurotoxicity. Biochem Biophys Res Commun 390: 1250-1254 (2009).
29. Hartman RE, Shah A, Fagan AM. Pomegranate juice decreases amyloid loadand improves behavior in a mouse model of Alzheimer's disease. Neurobiol Dis 506-515 (2006).
30. Rojanathammanee L, Puig KL, Combs CK. Pomegranate polyphenols and extract inhibit nuclear factor of activated T-cell activity and microglial activation in vitro and in a transgenic mouse model of Alzheimer disease. J Nutr1 43: 597-605 (2013).
31. Mertens-Talcott SU, Jilma-Stohlawetz P, Rios J, Hingorani L, Derendorf H. Absorption, metabolism, and antioxidant effects of pomegranate (Punica granatum l.) polyphenols after ingestion of a standardized extract in healthy human volunteers. J Agric Food Chem 54: 8956-8961 (2006).
32. Seeram NP, Lee R, Hardy ML, Heber D. Rapid large-scale purification of ellagitannins from pomegranate husk, a by-product of the commercial juice industry. Separation and Purification Technology 41: 49-55 (2005).
33. Jean-Gilles D, Li L, Vaidyanathan VG, King R, Cho B, Worthen DR, et al. Inhibitory effects of polyphenol punicalagin on type-II collagen degradation in vitro and inflammation in vivo. Chem Biol Interact 205: 90-99 (2013).
34. Lamb BT, Bardel KA, Kulnane LS, Anderson JJ, Holtz G, Wagner SL, et al. Amyloid production and deposition in mutant amyloid precursor protein and presenilin-1 yeast artificial chromosome transgenic mice. Nat Neurosci 2: 695-697 (1999).
35. Lamb BT, Call LM, Slunt HH, Bardel KA, Lawler AM, Eckman CB, et al. Altered metabolism of familial Alzheimer's diseaselinked amyloid precursor protein variants in yeast artificial chromosome transgenic mice. Hum Mol Genet 1535-1541 (1997).
36. Subaiea GM, Adwan LI, Ahmed AH, Stevens KE, Zawia NH. Short-term treatment with tolfenamic acid improves cognitive functions in Alzheimer's disease mice. Neurobiol Aging 34 (10): 2421-30 (2013).
37. Patel C, Dadhaniya P, Hingorani L, Soni MG. Safety assessments of pomegranate fruit extract: Acute and subchronic toxicity studies. Food and Chem. Toxicol 46: 2728-2735 (2008).
38. Parmar HS, Kar A. Medicinal values of fruit peels from Citrus sinensis, Punica granatum, and Musa paradisiaca with respect to alterations in tissue lipid peroxidation and serum concentration of glucose, insulin, and thyroid hormones. J Med Food 11: 376-381 (2008).
39. Abdel Moneim AE, Dkhil MA, Al-Quraishy S. Studies on the effect of pomegranate (Punica granatum) juice and peel on liver and kidney in adult male rats. J Med Plants Res 5: 5083-5088 (2011).
40. Pannangrong W, Wattanathorn J, Muchimapura S, Tiamkao S, Tong-Un T. Purple rice berry is neuroprotective and enhances cognition in a rat model of Alzheimer's disease. J Med Food 14:688-694 (2011).
41. Sehgal N, Gupta A, Valli RK, Joshi SD, Mills JT, Hamel E, et al. Withania somnifera reverses Alzheimer's disease pathology by enhancing low-density lipoprotein receptor-related protein in liver. Proc Natl Acad Sci USA 109: 3510-3515 (2012).
42. Gulinello M, Gertner M, Mendoza G, Schoenfeld BP, Oddo S, La Ferla F, et al. Validation of a 2-day water maze protocol in mice. Behav Brain Res 196: 220-227 (2009).
43. Vorhees CV, Williams MT. Morris water maze: procedures for assessing spatial and related forms of learning and memory. Nat Protoc 1: 848-858 (2006).
44. Hock BJ, Lattal KM, Kulnane LS, Abel T, Lamb BT. Pathology associated memory deficits in Swedish mutant genome-based amyloid precursor protein transgenic mice. Curr Aging Sci 2: 205-213 2009.
45. King DL, Arendash GW, Crawford F, Sterk T, Menendez J, Mullan MJ. Progressive and gender-dependent cognitive impairment in the APP (SW) transgenic mouse model for Alzheimer's disease. Behav Brain Res 103: 145-162 (1999).
46. Morishima-Kawashima M, Oshima N, Ogata H, Yamaguchi H, Yoshimura M, Sugihara S, et al. Effect of apolipoprotein E allele epsilon4 on the initial phase of amyloid beta-protein accumulation in the human brain. Am J Pathol 157: 2093-2099 (2000).
47. Wu J, Basha MR, Brock B, Cox DP, Cardozo-Pelaez F, McPherson CA, et al. Alzheimer's disease (AD)-like pathology in aged monkeys after infantile exposure to environmental metal lead (Pb): evidence for a developmental origin and environmental link for AD. J Neurosci 28: 3-9 (2008).
48. Luo WJ, Wang H, Li H, Kim BS, Shah S, Lee HJ, et al. PEN-2 and APH-1 coordinately regulate proteolytic processing of presenilin 1. J Biol Chem 278: 7850-7854 (2003).
49. Kurochkin IV, Goto S. Alzheimer's beta-amyloid peptide specifically interacts with and is degraded by insulin degrading enzyme. FEBS Lett 345: 33-37 (1994).
50. Qiu WQ, Walsh DM, Ye Z, Vekrellis K, Zhang J, Podlisny MB, et al. Insulin-degrading enzyme regulates extracellular levels of amyloid beta-protein by degradation. J Biol Chem 273: 32730-32738 (1998).
51. Malito E, Hulse RE, Tang WJ. Amyloid beta-degrading cryptidases: insulin degrading enzyme, presequence peptidase, and neprilysin. Cell Mol Life Sci 65: 2574-2585 (2008).
52. Yin YI, Bassit B, Zhu L, Yang X, Wang C, Li YM. {gamma}-Secretase Substrate Concentration Modulates the Abeta42/Abeta40 Ratio: IMPLICATIONS FOR ALZHEIMER DISEASE. J Biol Chem 282: 23639-23644 (2007).
53. Dai Q, Borenstein AR, Wu Y, Jackson JC, Larson EB. Fruit and Vegetable Juices and Alzheimer’s Disease: The Kame Project. Am J Med 199: 751-759 (2006).
54. Hughes TF, Andel R, Small BJ, Borenstein AR, Mortimer JA, Wolk A, et al. Midlife fruit and vegetable consumption and risk of dementia in later life in Swedish twins. Am J Geriatr Psychiatry 18: 413-420 (2010).
55. Frankland PW, Bontempi B. The organization of recent and remote memories. Nat Rev Neurosci 6: 119-130 (2005).
56. Teixeira CM, Pomedli SR, Maei HR, Kee N, Frankland PW. Involvement of the anterior cingulate cortex in the expression of remote spatial memory. J Neurosci 26:7555-7564 (2006).
57. Lalonde R. The neurobiological basis of spontaneous alternation. Neurosci Biobehav Rev 26: 91-104 (2002).
58. Butterfield DA, Griffin S, Munch G, Pasinetti GM. Amyloid betapeptide and amyloid pathology are central to the oxidative stress and inflammatory cascades under which Alzheimer's disease brain exists. J Alzheimers Dis 4: 193-201 (2002).
59. Walsh DM, Selkoe DJ. A beta oligomers -a decade of discovery. J Neurochem 101: 1172-1184 (2007).
60. Wang R, Wang B, He W, Zheng H. Wild-type presenilin 1 protects against Alzheimer disease mutation-induced amyloid pathology. J Biol Chem 281: 15330-15336 (2006).
61. Kim J, Onstead L, Randle S, Price R, Smithson L, Zwizinski C, et al. Abeta40 inhibits amyloid deposition in vivo. J Neurosci 27:627-633 (2007).
62. Yan Y, Wang C. Abeta40 protects non-toxic Abeta42 monomer from aggregation. J Mol Biol 369: 909-916 (2007).
63. Kuperstein I, Broersen K, Benilova I, Rozenski J, Jonckheere W, Debulpaep M, et al. Neurotoxicity of Alzheimer's disease Abeta peptides is induced by small changes in the Abeta42 to Abeta40 ratio. EMBO J 29:3408-3420 (2010).
64. Uemura K, Lill CM, Li X, Peters JA, Ivanov A, Fan Z,et al. Allosteric modulation of PS1/gamma-secretase conformation correlates with amyloid beta (42/40) ratio. PLoS One 4: e7893 (2009).
65. Kametani F. Epsilon-secretase: reduction of amyloid precursor protein epsilon-site cleavage in Alzheimer's disease. Curr Alzheimer Res 5: 165-171 (2008).
66. Lichtenthaler SF, Wang R, Grimm H, Uljon SN, Masters CL, Beyreuther K. Mechanism of the cleavage specificity of Alzheimer's disease gamma-secretase identified by phenylalaninescanning mutagenesis of the transmembrane domain of the amyloid precursor protein. Proc Natl Acad Sci USA 96: 3053-3058 (1999).
67. Ousson S, Saric A, Baguet A, Losberger C, Genoud S, Vilbois F, et al. Substrate determinants in the C99 juxtamembrane domains differentially affect gamma-secretase cleavage specificity and modulator pharmacology. J Neurochem 125: 610-619 (2013).
68. Peretto I, La Porta E. Gamma-secretase modulation and its promise for Alzheimer's disease: a medicinal chemistry perspective. Curr Top Med Chem 8: 38-46 (2008).
69. Marder K. Tarenflurbil in patients with mild Alzheimer's disease. Curr Neurol Neurosci Rep 10: 336-337 (2010).